Genetics of transfusion recipient alloimmunization: Can clues from susceptibility to autoimmunity pave the way?

Zohreh Tatari Calderone, Naomi L C Luban, Stanislav Vukmanovic

Research output: Contribution to journalReview article

11 Citations (Scopus)


The search for genetic determinants of alloimmunization in sickle cell disease transfusion recipients was based on two premises: i) that polymorphisms responsible for stronger immune and/or inflammatory responses and hemoglobin βS mutation were co-selected by malaria; and ii) that stronger responder status contributes to development of lupus. We found a marker of alloimmunization in the gene encoding for Ro52 protein, also known as Sjögren syndrome antigen 1 (SSA1) and TRIM21. Surprisingly, the nature of the association was opposite of that with lupus; the same variant of a polymorphism (rs660) that was associated with lupus incidence was also associated with induction of tolerance to red blood cell antigens during early childhood. The dual function of Ro52 can explain this apparent contradiction. We propose that other lupus/autoimmunity susceptibility loci may reveal roles of additional molecules in various aspects of alloimmunization induced by transfusion as well as during pregnancy.

Original languageEnglish
Pages (from-to)436-445
Number of pages10
JournalTransfusion Medicine and Hemotherapy
Issue number6
Publication statusPublished - 17 Dec 2014
Externally publishedYes



  • Alloimmunization
  • Antibodies
  • Autoimmunity
  • Red blood cells

ASJC Scopus subject areas

  • Immunology and Allergy
  • Hematology

Cite this